Food & function
Cure8 research brief
Why This Matters
This study provides preclinical evidence that an anthocyanin (cyanidin-3-O-glucoside) can reduce inflammation and preserve the intestinal barrier in a mouse colitis model, highlighting a possible dietary mechanism relevant to gut health and IBD research.
Who Should Pay Attention
Researchers, clinicians, and patients interested in nutritional or mechanistic preclinical IBD research
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This PubMed-listed animal study tested cyanidin-3-O-glucoside (C3G), a dietary anthocyanin, in a mouse model of colitis induced by dextran sulfate sodium (DSS). The abstract reports that oral C3G reduced typical disease measures in mice (weight loss, colon shortening, inflammation) and improved intestinal barrier markers (MUC2 and tight junction proteins).
Transcriptomic and network analyses pointed to the PI3K–Akt pathway and apoptosis as potential mechanisms, and the authors validated reduced epithelial apoptosis and changes in apoptosis-related proteins. The work is preclinical: findings are from an experimental mouse model and molecular analyses rather than human trials.
The article frames C3G as a potential functional food component that may protect intestinal barrier function via PI3K–Akt modulation and decreased epithelial cell apoptosis. If you’re curious about dietary anthocyanins, this study adds mechanistic animal-model evidence but does not show safety or efficacy in people with IBD.
It also does not replace standard medical treatment.
Keep In Mind
Findings come from a DSS-induced mouse model and integrated molecular analyses reported in the article abstract; human studies are needed before clinical recommendations.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationFood & function
AuthorsGuangyi Du, Jiaxin Li, Yang Xu +5 more
InstitutionDepartment of Food Science and Nutrition, College of Biosystems Engineering and Food Science, Zhejiang University, No. 866 Yuhangtang Road, Xihu District, Hangzhou, 310058, China. zjuchenwei@zju.edu.cn.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedSep 4, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Prunella vulgaris Polysaccharide Ameliorates DSS-Induced Ulcerative Colitis by Increasing the Abundance of Ligilactobacillus agilis to Inhibit Inflammation and Preserve Intestinal Barrier Integrity
A plant polysaccharide (PVP) reduced inflammation and preserved intestinal barrier proteins in a mouse model of ulcerative colitis, apparently by increasing a specific gut bacterium. This points to a microbiome-related...
Arctic Fox-Derived Lactiplantibacillus plantarum J3 Alleviates Colitis in Mice in Association with Strengthening of the Intestinal Barrier and Reshaping of the Intestinal Flora
This preclinical study suggests a fox-derived Lactiplantibacillus plantarum strain can reduce inflammation and improve intestinal barrier markers in cell and mouse models of colitis, which could inform future...
Extracellular Vesicles Derived from Elaeocarpus braceanus Alleviate DSS-Induced Ulcerative Colitis in Mice Through Multiple Pathways
This study describes a new plant-derived nanoparticle (EBDEVs) that reduced inflammation and improved colon health in a mouse model of ulcerative colitis and altered the gut microbiota — early evidence that may guide...